Endothelial Glycocalyx Impairment in Disease: Focus on Hyaluronan Shedding
- PMID: 32035885
- DOI: 10.1016/j.ajpath.2019.11.016
Endothelial Glycocalyx Impairment in Disease: Focus on Hyaluronan Shedding
Abstract
Hyaluronan (HA) is a ubiquitous glycosaminoglycan of the extracellular matrix. It is present in the endothelial glycocalyx covering the apical surface of endothelial cells. The endothelial glycocalyx regulates blood vessel permeability and homeostasis. HA plays a central role in numerous functions of the endothelial surface layer, protecting the endothelial cells, regulating the barrier permeability, and ensuring mechanosensing, which is essential to nitric oxide production and flow-induced vasodilation. During acute injury, inflammatory conditions, or many other pathologic conditions, the endothelial glycocalyx is damaged, and its degradation is accompanied by shedding of one or more glycocalyx components into the blood. Syndecan-1, heparan sulfate, and HA are the main components whose shedding has been claimed to represent the endothelial glycocalyx state of health. This review focuses on endothelial glycocalyx HA and highlights its key roles in the functions of the endothelial glycocalyx, its shedding in several pathologic conditions such as sepsis, diabetes, chronic and acute kidney injury, ischemia/reperfusion, atherosclerosis, and inflammation, which are all accompanied by increased circulating HA levels. Plasma/serum HA level is becoming recognized as a biomarker of endothelial glycocalyx damage in select pathologies. Hyaluronidase, the main HA-degrading enzyme, and its involvement in the impairment of endothelial glycocalyx are also addressed.
Copyright © 2020 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Endothelial Glycocalyx as a Shield Against Diabetic Vascular Complications: Involvement of Hyaluronan and Hyaluronidases.Arterioscler Thromb Vasc Biol. 2018 Jul;38(7):1427-1439. doi: 10.1161/ATVBAHA.118.310839. Epub 2018 Jun 7. Arterioscler Thromb Vasc Biol. 2018. PMID: 29880486 Free PMC article. Review.
-
Endothelial Glycocalyx Hyaluronan: Regulation and Role in Prevention of Diabetic Complications.Am J Pathol. 2020 Apr;190(4):781-790. doi: 10.1016/j.ajpath.2019.07.022. Epub 2020 Feb 6. Am J Pathol. 2020. PMID: 32035886 Review.
-
Degradation of the endothelial glycocalyx in clinical settings: searching for the sheddases.Br J Clin Pharmacol. 2015 Sep;80(3):389-402. doi: 10.1111/bcp.12629. Epub 2015 May 22. Br J Clin Pharmacol. 2015. PMID: 25778676 Free PMC article. Review.
-
COVID-19 generates hyaluronan fragments that directly induce endothelial barrier dysfunction.JCI Insight. 2021 Sep 8;6(17):e147472. doi: 10.1172/jci.insight.147472. JCI Insight. 2021. PMID: 34314391 Free PMC article.
-
Damage of the endothelial glycocalyx in chronic kidney disease.Atherosclerosis. 2014 Jun;234(2):335-43. doi: 10.1016/j.atherosclerosis.2014.03.016. Epub 2014 Mar 29. Atherosclerosis. 2014. PMID: 24727235
Cited by
-
Insights into the Molecular Mechanism of Endothelial Glycocalyx Dysfunction during Heart Surgery.Curr Issues Mol Biol. 2024 Apr 23;46(5):3794-3809. doi: 10.3390/cimb46050236. Curr Issues Mol Biol. 2024. PMID: 38785504 Free PMC article. Review.
-
Deciphering the triad of endothelial glycocalyx, von Willebrand Factor, and P-selectin in inflammation-induced coagulation.Front Cell Dev Biol. 2024 Apr 30;12:1372355. doi: 10.3389/fcell.2024.1372355. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 38745860 Free PMC article. Review.
-
Basal endothelial glycocalyx's response to shear stress: a review of structure, function, and clinical implications.Front Cell Dev Biol. 2024 Mar 18;12:1371769. doi: 10.3389/fcell.2024.1371769. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 38562144 Free PMC article. Review.
-
Role of endothelial hyaluronan in peritoneal membrane transport and disease conditions during peritoneal dialysis.Sci Rep. 2024 Mar 28;14(1):7412. doi: 10.1038/s41598-024-58148-x. Sci Rep. 2024. PMID: 38548914 Free PMC article.
-
Hyaluronidase inhibitor sHA2.75 alleviates ischemia-reperfusion-induced acute kidney injury.Cell Cycle. 2024 Feb;23(3):248-261. doi: 10.1080/15384101.2024.2309019. Epub 2024 Mar 25. Cell Cycle. 2024. PMID: 38526145
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical